KATHLEEN STAGG: Open Payments
NPI 1922483189 · SAFETY HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,226 in 172 payments from 23 companies in 2025. Trend: 2023 $3,416 · 2024 $3,248 · 2025 $4,226
Food & beverage: $4,110Education: $115
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $642 |
| GlaxoSmithKline, LLC. | 29 | $630 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $322 |
| Insmed, Inc. | 11 | $297 |
| United Therapeutics Corporation | 11 | $293 |
| GENZYME CORPORATION | 6 | $212 |
| Regeneron Healthcare Solutions, Inc. | 7 | $211 |
| Actelion Pharmaceuticals US, Inc. | 14 | $208 |
| Verona Pharma, Inc. | 7 | $186 |
| Amgen Inc. | 11 | $182 |
Products named: DUPIXENT, NUCALA, Arikayce, Tyvaso, AIRSUPRA, FASENRA, OFEV, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
